Us Bancorp »

Celldex Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 670 41.97
2023-12-31 $24k 599 39.66
2023-09-30 $3.3k 119 27.52
2023-06-30 $12k 349 33.93
2023-03-31 $15k 406 35.98
2022-12-31 $18k 406 44.57
2022-09-30 $11k 406 27.09
2022-06-30 $11k 406 27.09
2022-03-31 $14k 406 34.48
2021-12-31 $16k 406 39.41
2021-09-30 $22k 406 54.19
2021-06-30 $14k 406 34.48
2021-03-31 $8.0k 406 19.70
2020-12-31 $6.0k 356 16.85
2020-06-30 $0 6 0.00